Floatz logo

Folic Acid

Other Sickle-cell Disorders With Crisis, Unspecified

Beni-Suef UniversitySmall moleculePhase 2/3Dormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
95/ 100

Competitive context

135 Active assets in the Other Sickle-cell Disorders With Crisis, Unspecified cohort.

Asset / SponsorPhaseRating
Glutamine
Ain Shams University
Phase 4BBB
Hydroxyurea
St. Jude Children's Research Hospital
Phase 4BB
MAGNESIUM METALLICUM
Medical College of Wisconsin
Phase 3BB
Crizanlizumab
Novartis Pharmaceuticals
Phase 4BB
FILGRASTIM
St. Jude Children's Research Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Folic Acid is also rated in:

hyperhomocysteinemiaDormant
BBB
Indicative ·
76 / 100
View asset →
myocardial infarctionDormant
BBB
Indicative ·
72 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →